Muteins of human tear lipocalin capable of binding lymphocyte-activation gene 3 (LAG-3) and methods of use thereof
US-10501510-B2 · Dec 10, 2019 · US
This page is not indexed by search engines while we improve data quality.
Pieris Pharmaceuticals Gmbh patents in 2019
Pieris Pharmaceuticals Gmbh was listed as an assignee on 14 patent publications in 2019.
| Metric | Value |
|---|---|
| Company | Pieris Pharmaceuticals Gmbh |
| Year | 2019 |
| Patents | 14 |
Patents
Representative publications for Pieris Pharmaceuticals Gmbh in 2019.
Lipocalin muteins with binding affinity for lag-3
US-2019345207-A1 · Nov 14, 2019 · US
Novel proteins specific for calcitonin gene-related peptide
US-2019338002-A1 · Nov 7, 2019 · US
Muteins of human lipocalin 2 with affinity for glypican-3 (gpc3)
US-2019309037-A1 · Oct 10, 2019 · US
Proteins specific for calcitonin gene-related peptide
US-10400016-B2 · Sep 3, 2019 · US
Top CPC classifications
Most common classification codes for Pieris Pharmaceuticals Gmbh in 2019.
| CPC | Patents |
|---|---|
| A61P35/00 | 12 |
| C07K14/47 | 12 |
| A61K38/00 | 10 |
| A61P43/00 | 10 |
| A61K38/1709 | 5 |
Related pages
Navigate to parent entity pages.